Agreement signedPublished 31 Jul 2024
SERB Pharmaceuticals /
Emergent BioSolutions Inc.
SERB Pharmaceuticals agrees to buy Emergent BioSolutions Inc.
01 / BuyerSERB Pharmaceuticals
02 / TargetEmergent BioSolutions Inc.
Source-verifiedWhat happened
SERB Pharmaceuticals agreed to acquire Emergent BioSolutions Inc. for $75 million, according to a filing dated July 31, 2024.
The source
Everything on this page comes from the source below.
01
Source · Original source
SERB Pharmaceuticals agrees to buy Emergent BioSolutions Inc.
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly